Biotech firm: Graphcore IPUs faster for AI-based drug discovery than GPUs

Someone's got to keep, say, Nvidia on its toes

In the race to provide the best machine-learning accelerators, one of Nvidia's top challengers has claimed a victory in the biotech space, London firm LabGenius, which said Graphcore's intelligence processing units (IPUs) provide significantly faster performance for AI-based drug discovery than some unidentified traditional GPUs.…

ai biotech discovery drug discovery gpus graphcore